Matthew Cato

Senior Director Cell & Gene Therapy • Mission Bio

Matthew Cato is a business and market development leader who specializes in cell and gene therapies and precision medicine. With a background in immunology and biotechnology, he focuses on strategic commercial development for single-cell technology to advance cell and gene therapeutic solutions

Also Speaking

Isaac Zentner

Associate Director Process Development • Carisma Therapeutics

Jenny Holt

Senior Vice President, Programme and Portfolio Management • Ray Therapeutics

Lesley Chan

Director of Process Innovation • bluebird bio

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.